[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@psil_ai "#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-15 13:01:20 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program approved by UK MHRA for CYB003 receives Breakthrough Therapy Designation from FDA for MDD." #innovativetreatment #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-24 19:01:15 UTC XX followers, XX engagements

""CYBN receives MHRA approval for EMBRACE second Phase X study in PARADIGM program evaluating CYB003 for MDD. Expected enrollment of XXX participants across XX clinical sites. #mentalhealth" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-21 16:01:14 UTC XX followers, XXX engagements

""#Cybin's Phase X study EMBRACE to enroll XXX participants at XX sites in US Europe & Australia. Approval from UK MHRA marks progress in developing new treatments for MDD. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-18 16:01:10 UTC XX followers, XXX engagements

"#Cybin receives MHRA approval to commence second Phase X study EMBRACE in PARADIGM program for CYB003. Expected enrollment of XXX participants to generate critical late-stage data for MDD treatment. #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-22 19:01:13 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program approved by UK MHRA for CYB003 receives Breakthrough Therapy Designation from FDA for MDD." #clinicaltrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-18 19:01:19 UTC XX followers, XXX engagements

""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study expected to enroll XXX participants and generate critical data for MDD treatment. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-23 13:01:18 UTC XX followers, XXX engagements

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-15 16:01:19 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program approved by UK MHRA for Cybin's CYB003. Expected enrollment of XXX participants to generate critical data for MDD treatment. #pharma" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-21 19:01:16 UTC XX followers, XXX engagements

"#Cybin's Phase X PARADIGM program progresses with EMBRACE study's approval by UK MHRA. XXX participants to be enrolled across US Europe and Australia aiming to transform MDD treatment. #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-23 19:01:21 UTC XX followers, XXX engagements

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-14 19:01:10 UTC XX followers, XXX engagements

""EMBRACE the second Phase X study in PARADIGM approved by MHRA to enroll XXX participants at XX sites. CYBN aims to transform MDD treatment with CYB003. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-22 16:01:19 UTC XX followers, XXX engagements

""CYBN receives MHRA approval for Phase X EMBRACE study expected to enroll XXX participants at XX sites. Potential to transform MDD treatment." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-18 13:01:17 UTC XX followers, XXX engagements

""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants for critical late-stage data on CYB003's potential as MDD treatment. #biotech" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-22 13:01:13 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming MDD treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-21 13:01:17 UTC XX followers, XXX engagements

""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants and generate critical data for CYB003 in treating MDD. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-17 16:01:01 UTC XX followers, XXX engagements

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-16 16:01:14 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming depression treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-17 13:01:08 UTC XX followers, XXX engagements

""CYBN's Phase X study EMBRACE approved by UK MHRA aims to enroll XXX participants across US Europe and Australia. Positive signs for innovative therapeutics in mental health sector." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-24 16:01:20 UTC XX followers, XXX engagements

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #biotech #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-16 13:01:18 UTC XX followers, XXX engagements

""Cybin's Phase X study EMBRACE approved by UK MHRA to enroll XXX participants for CYB003 a deuterated psilocin analog shows potential for transforming MDD treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-24 13:01:13 UTC XX followers, XXX engagements

"#Cybin reports progress in Phase X CYB003 PARADIGM program strengthens commercial partnerships and expects to enroll XXX participants in APPROACH study. #Neuropsychiatry #ClinicalTrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-14 13:01:30 UTC XX followers, XXX engagements

""Phase X study EMBRACE part of PARADIGM program for CYB003 receives MHRA approval and aims to enroll XXX participants signaling potential for transforming MDD treatment. #innovativetherapeutics" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai Avatar @psil_ai on X 2025-07-23 16:01:11 UTC XX followers, XXX engagements